对于糖尿病患者的粘合性囊炎的干预不同于没有糖尿病的患者的干预吗? : 一个系统的审查
1Department of Rehabilitation, Chongqing Nanchuan Traditional Chinese Medicine Hospital, Chongqing, China.
Medicine
|November 19, 2024
概括
粘合性囊炎 (AC) 治疗对糖尿病患者和非糖尿病患者都显示出积极的结果. 然而,那些患有糖尿病的人可能会经历更糟糕的结果,需要额外的康复以及血糖控制.
科学领域:
- 整形外科 整形外科 整形外科
- 内分泌学 在内分泌学.
- 物理医学和康复 康复
背景情况:
- 粘着性囊炎 (AC),或结的肩膀,导致疼痛和有限的运动范围,影响日常生活.
- 糖尿病 (DM) 是已知的AC风险因素,往往导致更严重的关节限制.
研究的目的:
- 为了比较在患有和没有糖尿病的患者中AC治疗的临床有效性.
- 为了确定糖尿病AC患者是否需要专门的干预措施.
主要方法:
- 在PubMed NCBI和Embase上进行了系统的文献搜索.
- 包括在过去30年内发表的研究,重点关注AC和DM.
主要成果:
- 分析了9项涉及551名参与者的研究 (166名糖尿病人,394名非糖尿病人).
- 治疗包括冲击波疗法,水解,关节镜释放和操纵.
- 虽然两组都显示出积极的疗效,但在一些研究中,非糖尿病患者在疼痛,问卷和运动范围方面表现出更好的改善.
结论:
- 目前的AC治疗对糖尿病患者和非糖尿病患者都有效.
- 有证据表明,患有DM的AC可能对标准治疗的反应不那么有利.
- 患有AC的糖尿病患者可能会从补充康复和一致的血糖管理中受益.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
146
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
146
Dipeptidyl Peptidase 4 Inhibitors
172
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
172
Diabetes: Management and Pharmacotherapy
236
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
236
Oral Hypoglycemic Agents: Biguanides and Glitazones
174
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
174
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Acute Pancreatitis II: Clinical Manifestations and Management
93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93


